Xin Da Guo Ji Kong Gu·2025-12-09 02:23Market Overview - The Hang Seng Index (HSI) has short-term support at the 25,000 point level, with recent hawkish signals from the Federal Reserve indicating limited rate cut space in 2026. Economic tensions between China and the US have eased temporarily, but corporate earnings in Hong Kong are unlikely to improve significantly in the short term due to a lack of strong policy signals from mainland China [2][4][6]. Economic Focus - China's exports in November increased by 5.9% year-on-year, surpassing expectations, while imports rose by 1.9%. The trade surplus for November was reported at USD 111.68 billion. For the first eleven months of the year, exports grew by 5.4%, and imports fell by 0.6%, resulting in a cumulative trade surplus of USD 1,075.848 billion [4][8]. - The Central Committee of the Communist Party of China emphasized the need for stable economic progress in 2026, advocating for a proactive fiscal policy and moderately loose monetary policy to enhance macroeconomic governance [4][8]. - The US Treasury Secretary projected a 3% GDP growth for the year, citing strong holiday season consumer spending [4][8]. Company News - Meituan (3690) launched the LongCat-Image model for image generation, aiming to provide high-performance options for developers [9]. - Chow Tai Fook Jewelry (1929) underwent a significant equity restructuring, with the Cheng family injecting HKD 47.3 billion worth of shares into the company [9]. - Vanke (2202) is facing investor concerns regarding its bond extension plan ahead of a crucial vote [9]. - New energy vehicles in China achieved a retail penetration rate of 59.3% in November, reflecting a 7 percentage point increase year-on-year [8][9]. Stock Market Performance - The Hang Seng Index closed at 25,765, down 1.23% year-to-date, while the Hang Seng Tech Index showed a year-to-date increase of 26.73% [5][6]. - The US stock market experienced slight declines, with major indices falling between 0.1% and 0.5% [6]. Sector Outlook - The AI sector, particularly companies involved in AI glasses and smartphones, is expected to benefit from recent product launches and market trends [7]. - The biopharmaceutical sector is also poised for growth due to rising flu cases and favorable financing conditions [7].